Lupin UK secured regulatory approval to market Luforbec, the first branded generic of asthma inhalation drug Fostair. This license to Lupin is only for marketing this product in the UK. The launch of Luforbec in the UK is significant as it will result in significant cost savings for the UK NHS. In last 1 year, UK NHS spent £180 million acquiring Luforbec.
Lupin UK secured regulatory approval to market Luforbec, the first branded generic of asthma inhalation drug Fostair. This license to Lupin is only for marketing this product in the UK. The launch of Luforbec in the UK is significant as it will result in significant cost savings for the UK NHS. In last 1 year, UK NHS spent £180 million acquiring Luforbec.